CD8A and neoplasm: After studying samples from 120 NSCLC adenocarcinoma patients with disease stages ranging from I to III Barua et al. (2018) reported tumour cell and regulatory T-cell (Treg) interactions to be significantly associated with worse survival, while the co-presence of cytotoxic CD8+ T lymphocytes resulted in better survival.